223 related articles for article (PubMed ID: 33378964)
1. QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy.
Wei H; Wang L; An Z; Xie H; Liu W; Du Q; Guo Y; Wu X; Li S; Shi Y; Zhang X; Liu H
Biomed Pharmacother; 2021 Jan; 133():111061. PubMed ID: 33378964
[TBL] [Abstract][Full Text] [Related]
2. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.
Zhao J; Zhang QL; Shen JH; Wang K; Liu J
Acta Pharmacol Sin; 2019 Apr; 40(4):507-513. PubMed ID: 29941869
[TBL] [Abstract][Full Text] [Related]
3. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
[TBL] [Abstract][Full Text] [Related]
4. QiDiTangShen Granules Reduced Diabetic Kidney Injury by Regulating the Phosphorylation Balance of the Tyrosine and Serine Residues of Insulin Receptor Substrate 1.
Gao X; Liu H; An Z; He Q
Evid Based Complement Alternat Med; 2018; 2018():2503849. PubMed ID: 30050584
[TBL] [Abstract][Full Text] [Related]
5. QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
Gao F; Zhou Y; Yu B; Xie H; Shi Y; Zhang X; Liu H
Heliyon; 2024 Jan; 10(1):e23535. PubMed ID: 38223704
[TBL] [Abstract][Full Text] [Related]
6. QiDiTangShen Granules Activate Renal Nutrient-Sensing Associated Autophagy in db/db Mice.
Wang X; Zhao L; Ajay AK; Jiao B; Zhang X; Wang C; Gao X; Yuan Z; Liu H; Liu WJ
Front Physiol; 2019; 10():1224. PubMed ID: 31632286
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol improves diabetic kidney disease by modulating the gut microbiota-short chain fatty acids axis in
Yan H; Zhang Y; Lin X; Huang J; Zhang F; Chen C; Ren H; Zheng S; Yang J; Hui S
Int J Food Sci Nutr; 2024 May; 75(3):264-276. PubMed ID: 38238900
[TBL] [Abstract][Full Text] [Related]
9. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice.
Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H
Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case.
Zhao L; Ma P; Peng Y; Wang M; Peng C; Zhang Y; Li X
Phytomedicine; 2021 Mar; 83():153477. PubMed ID: 33545549
[TBL] [Abstract][Full Text] [Related]
11. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
[TBL] [Abstract][Full Text] [Related]
12. Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor.
Tveter KM; Villa-Rodriguez JA; Cabales AJ; Zhang L; Bawagan FG; Duran RM; Roopchand DE
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32771984
[TBL] [Abstract][Full Text] [Related]
13. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
[TBL] [Abstract][Full Text] [Related]
16. Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota.
Chen Q; Ren D; Wu J; Yu H; Chen X; Wang J; Zhang Y; Liu M; Wang T
J Nat Med; 2021 Jan; 75(1):84-98. PubMed ID: 32997272
[TBL] [Abstract][Full Text] [Related]
17. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
18. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
19. Modification effects of SanWei GanJiang Powder on liver and intestinal damage through reversing bile acid homeostasis.
Li N; Wang B; Wu Y; Luo X; Chen Z; Sang C; Xiong T
Biomed Pharmacother; 2019 Aug; 116():109044. PubMed ID: 31174088
[TBL] [Abstract][Full Text] [Related]
20.
Zhou Q; Yang F; Li Z; Qu Q; Zhao C; Liu X; Yang P; Han L; Shi Y; Shi X
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35617337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]